The Role of Glucagon-Like Peptide 1 (GLP1) in Type 3 Diabetes: GLP-1 Controls Insulin Resistance, Neuroinflammation and Neurogenesis in the Brain
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Role of Glucagon-Like Peptide 1 (GLP1) in Type 3 Diabetes: GLP-1 Controls Insulin Resistance, Neuroinflammation and Neurogenesis in the Brain
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 18, Issue 11, Pages 2493
Publisher
MDPI AG
Online
2017-11-22
DOI
10.3390/ijms18112493
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Brain GLP-1/IGF-1 Signaling and Autophagy Mediate Exendin-4 Protection Against Apoptosis in Type 2 Diabetic Rats
- (2017) Emanuel Candeias et al. MOLECULAR NEUROBIOLOGY
- Energy and the Alzheimer brain
- (2017) Mortimer Mamelak NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Diabetes and Alzheimer’s disease crosstalk
- (2016) David Baglietto-Vargas et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Selective Insulin Resistance in Homeostatic and Cognitive Control Brain Areas in Overweight and Obese Adults
- (2015) Stephanie Kullmann et al. DIABETES CARE
- Association of low GLP-1 with oxidative stress is related to cardiac disease and outcome in patients with type 2 diabetes mellitus: A pilot study
- (2015) Susana Ravassa et al. FREE RADICAL BIOLOGY AND MEDICINE
- Aberrant insulin signaling in Alzheimer's disease: current knowledge
- (2015) Gaurav Bedse et al. Frontiers in Neuroscience
- Distribution and characterisation of Glucagon-like peptide-1 receptor expressing cells in the mouse brain
- (2015) Simon C. Cork et al. Molecular Metabolism
- The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease
- (2014) Konrad Talbot et al. Alzheimers & Dementia
- Elevated risk of type 2 diabetes for development of Alzheimer disease: A key role for oxidative stress in brain
- (2014) D. Allan Butterfield et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- WNT Signaling: an Emerging Mediator of Cancer Cell Metabolism?
- (2014) Victoria Sherwood MOLECULAR AND CELLULAR BIOLOGY
- Exendin-4 Reduces Ischemic Brain Injury in Normal and Aged Type 2 Diabetic Mice and Promotes Microglial M2 Polarization
- (2014) Vladimer Darsalia et al. PLoS One
- The role of gastrointestinal hormones in the pathogenesis of obesity and type 2 diabetes
- (2014) Edyta Adamska et al. Przeglad Gastroenterologiczny
- Brain network markers of abnormal cerebral glucose metabolism and blood flow in Parkinson’s disease
- (2014) Shichun Peng et al. Neuroscience Bulletin
- Melatonin acts through MT1/MT2 receptors to activate hypothalamic Akt and suppress hepatic gluconeogenesis in rats
- (2013) Juliana A. Faria et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- History of Medically Treated Diabetes and Risk of Alzheimer Disease in a Nationwide Case-Control Study
- (2013) A.-M. Tolppanen et al. DIABETES CARE
- 13C-labelled microdialysis studies of cerebral metabolism in TBI patients
- (2013) Keri L.H. Carpenter et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- PI3-kinase/Akt/mTOR signaling: Impaired on/off switches in aging, cognitive decline and Alzheimer's disease
- (2013) Cora O' Neill EXPERIMENTAL GERONTOLOGY
- Central effects of GLP-1: new opportunities for treatments of neurodegenerative diseases
- (2013) Christian Hölscher JOURNAL OF ENDOCRINOLOGY
- Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease
- (2013) Paula L. McClean et al. NEUROPHARMACOLOGY
- Chronic Treatment with the GLP1 Analogue Liraglutide Increases Cell Proliferation and Differentiation into Neurons in an AD Mouse Model
- (2013) Vadivel Parthsarathy et al. PLoS One
- Animal Models of Alzheimer Disease
- (2013) F. M. LaFerla et al. Cold Spring Harbor Perspectives in Medicine
- Dementia and cognitive decline in type 2 diabetes and prediabetic stages: towards targeted interventions
- (2013) Geert Jan Biessels et al. Lancet Diabetes & Endocrinology
- Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis
- (2012) Kerry Hunter et al. BMC NEUROSCIENCE
- The effect of ageing on neurogenesis and oxidative stress in the APPswe/PS1deltaE9 mouse model of Alzheimer's disease
- (2012) Alison Hamilton et al. BRAIN RESEARCH
- Neuroprotective and neurotrophic actions of glucagon-like peptide-1: an emerging opportunity to treat neurodegenerative and cerebrovascular disorders
- (2012) Isidro Salcedo et al. BRITISH JOURNAL OF PHARMACOLOGY
- Neurodevelopmental effects of insulin-like growth factor signaling
- (2012) John O’Kusky et al. FRONTIERS IN NEUROENDOCRINOLOGY
- Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline
- (2012) Konrad Talbot et al. JOURNAL OF CLINICAL INVESTIGATION
- Amyloid- assessed by florbetapir F 18 PET and 18-month cognitive decline: A multicenter study
- (2012) P. M. Doraiswamy et al. NEUROLOGY
- Insulin in the brain: There and back again
- (2012) William A. Banks et al. PHARMACOLOGY & THERAPEUTICS
- Neuronal and intracellular signaling pathways mediating GLP-1 energy balance and glycemic effects
- (2012) Matthew R. Hayes PHYSIOLOGY & BEHAVIOR
- Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment
- (2011) Suzanne Craft ARCHIVES OF NEUROLOGY
- Neuroprotective properties of GLP-1: theoretical and practical applications
- (2011) Jens Juul Holst et al. CURRENT MEDICAL RESEARCH AND OPINION
- Insulin biosynthesis in neuronal progenitors derived from adult hippocampus and the olfactory bulb
- (2011) Tomoko Kuwabara et al. EMBO Molecular Medicine
- Hyperphagia and Increased Fat Accumulation in Two Models of Chronic CNS Glucagon-Like Peptide-1 Loss of Function
- (2011) J. G. Barrera et al. JOURNAL OF NEUROSCIENCE
- The Diabetes Drug Liraglutide Prevents Degenerative Processes in a Mouse Model of Alzheimer's Disease
- (2011) P. L. McClean et al. JOURNAL OF NEUROSCIENCE
- Novel GLP-1 mimetics developed to treat type 2 diabetes promote progenitor cell proliferation in the brain
- (2011) A. Hamilton et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Preproglucagon neurons project widely to autonomic control areas in the mouse brain
- (2011) I.J. Llewellyn-Smith et al. NEUROSCIENCE
- Diabetes mellitus and Alzheimer's disease: shared pathology and treatment?
- (2010) Kawser Akter et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- The glucagon-like peptide 1 receptor agonist exendin-4 improves reference memory performance and decreases immobility in the forced swim test
- (2010) Ruben Isacson et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Alzheimer's Disease
- (2010) Henry W. Querfurth et al. NEW ENGLAND JOURNAL OF MEDICINE
- Role of the glucagon-like-peptide-1 receptor in the control of energy balance
- (2010) Matthew R. Hayes et al. PHYSIOLOGY & BEHAVIOR
- Preproglucagon derived peptides GLP-1, GLP-2 and oxyntomodulin in the CNS: Role of peripherally secreted and centrally produced peptides
- (2010) Niels Vrang et al. PROGRESS IN NEUROBIOLOGY
- Impairment of synaptic plasticity and memory formation in GLP-1 receptor KO mice: Interaction between type 2 diabetes and Alzheimer's disease
- (2009) Talib Abbas et al. BEHAVIOURAL BRAIN RESEARCH
- Glucagon-like peptide-1 analogues enhance synaptic plasticity in the brain: A link between diabetes and Alzheimer's disease
- (2009) Paula L. McClean et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Incretin-based therapies for type 2 diabetes mellitus
- (2009) Julie A. Lovshin et al. Nature Reviews Endocrinology
- Impaired neurogenesis, neuronal loss, and brain functional deficits in the APPxPS1-Ki mouse model of Alzheimer's disease
- (2009) A. Faure et al. NEUROBIOLOGY OF AGING
- Glucagon-like peptide 1 receptor stimulation by exendin-4 reverses key deficits in distinct rodent models of Parkinson's disease
- (2008) Alexander Harkavyi et al. Journal of Neuroinflammation
- Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of parkinson's disease
- (2007) Göran Bertilsson et al. JOURNAL OF NEUROSCIENCE RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More